Movatterモバイル変換


[0]ホーム

URL:


US3826255A - Intermittent positive pressure breathing manifold - Google Patents

Intermittent positive pressure breathing manifold
Download PDF

Info

Publication number
US3826255A
US3826255AUS00265390AUS26539072AUS3826255AUS 3826255 AUS3826255 AUS 3826255AUS 00265390 AUS00265390 AUS 00265390AUS 26539072 AUS26539072 AUS 26539072AUS 3826255 AUS3826255 AUS 3826255A
Authority
US
United States
Prior art keywords
gas
cap
main tube
nebulizer
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00265390A
Inventor
H Havstad
D Diedrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CREDITANSTALT-BANKVEREIN
Original Assignee
Hudson Oxygen Therapy Sales Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hudson Oxygen Therapy Sales CofiledCriticalHudson Oxygen Therapy Sales Co
Priority to US00265390ApriorityCriticalpatent/US3826255A/en
Priority to CA173,136Aprioritypatent/CA1003292A/en
Priority to GB5159574Aprioritypatent/GB1431082A/en
Priority to GB2685873Aprioritypatent/GB1431081A/en
Priority to ZA733952Aprioritypatent/ZA733952B/en
Priority to NL7308327Aprioritypatent/NL7308327A/xx
Priority to AU57048/73Aprioritypatent/AU468299B2/en
Priority to DE2331525Aprioritypatent/DE2331525C3/en
Priority to SE7308763Aprioritypatent/SE402865B/en
Priority to NO2577/73Aprioritypatent/NO135345C/en
Priority to BE132521Aprioritypatent/BE801216A/en
Priority to JP48070402Aprioritypatent/JPS5131480B2/ja
Application grantedgrantedCritical
Publication of US3826255ApublicationCriticalpatent/US3826255A/en
Priority to JP49093770Aprioritypatent/JPS5239277B2/ja
Assigned to FIRST INTERSTATE BANK OF CALIFORNIAreassignmentFIRST INTERSTATE BANK OF CALIFORNIASECURITY INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: HUDSON RESPIRATORY CARE, INC.
Assigned to HOMEFED BANK, F.S.B.reassignmentHOMEFED BANK, F.S.B.SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: HUDSON RESPIRATORY CARE INC.
Anticipated expirationlegal-statusCritical
Assigned to CREDITANSTALT-BANKVEREINreassignmentCREDITANSTALT-BANKVEREINASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: HUDSON RESPIRATORY CARE INC.
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

An improved intermittent positive pressure breathing manifold device comprises a substantially vertical main tube having open upper and lower ends, a diaphragm adjacent the upper main tube opening for intermittent closing thereof and which diaphragm is in sealing engagement with an upper cap portion located above the main tube, an exhalation port adjacent the upper main tube end and in communication with the lower main tube opening, and first and second gas ports along the main tube between the upper and lower main tube ends. A preferred embodiment includes an improved nebulizer incorporating an air nozzle and coaxial aspirator cap each having concentric orifices substantially aligned with the central vertical axis of the main manifold tube.

Description

' United-States Patent 1191 Havstad et a1.
.[11] 1 3,826,255 1451 July 30, 1974 1 INTERMITTENT POSITIVE PRESSURE BREATHING MANIFOLD [75] lnventors: Harold R. Havstad, Lakewood;
Donald F. Diedrich, Temecula, both of Calif.
[73] Assignee: Hudson Oxygen Therapy Sales Company, Temecula, Calif.
22 Filed; June 22,1972 [21] Appl. No.: 265,390
[52] U.S. Cl. 128/194, 239/338 [51] Int. Cl A61m 11/00 [58] Field of Search 128/194, 195, 196, 185,
[56] References Cited UNITED STATES PATENTS 2.069.455 2/1937 Massa 239/338 3,097,645 7/1963 Lester....; 128/194 3,221,733 12/1965 Beasley 128/1456 3,234,932 2/1966 Bird ct 128/1456 3.362.404 H1968 Beasley 128/1458 3,468.307 9/1969 Cummins 128/1455 5/1971 Takaoka 128/194 3,584,621 6/1971 Bird et al. 128/1458 3,664,337 128/194 5/1972 Lindsey et a1.
' Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Jerry R. Seiler I 57 ABSTRACT An improved intermittent positive pressure breathing manifold device comprises a substantially vertical main tube having open upper and lower ends, a diaphragm adjacent the upper main tube opening for intermittent closing thereof and which diaphragm is in sealing engagement with an uppercap portion located above the main tube, an exhalation port adjacent the upper main tube end and in communication with the lower main tube opening, and first and second gas ports along the main tube between the upper and lower main tube ends. A preferred embodiment includes an improved nebulizer incorporating an air nozzle and coaxial aspirator cap each having concentric orifices substantially aligned with the central vertical axis of the main manifold tube.
10 Claims, 12 Drawing Figures FIG. I
SHEET 28F 5 PATENIEB FIGURE 3 PAIENIEBMB B suEnu or 5 FIGURE 5% FIG. .7-
FIG. 6
FIGURE 8 BACKGROUND OF THE INVENTION Intermittent positive pressure breathing devices, commonly referred to as IPPB devices have been utilized for some time. The most commonly known devices are the Bird and Bennett IPPB units and incorporate various valves and pressure regulating means as generally described, for example, in U.S. Pat. Nos. 3,234,932 and 3,265,061, respectively-These units deliver oxygen or oxygen enriched gas mixture to a patient under pressure upon inspiration. As the patients lungs become filled, the gas flow is automatically terminated by flow sensing means and the patient may exhale normally during the breathing cycle. The devices are also sometimes referred to as respirators, ventilators or respiration control units. Again, these and similar devices supply the air or oxygen enriched gases to a patient under pressure during the inhalation breathing phase and, through the various valves and flow sensing means terminate the oxygen or air flow once the lungs have been filled to the desired capacity.
The above-described devices, hereinafter referred to as control units, are'used in combination with a gas delivery assembly of the type described in U.S. Pat. No. 3,265 ,06l or breather head assembly disclosed in U.S. Pat. No. 3,234,932 or control and exhaust valve assembly such as disclosed in U.S. Pat. No. 3,584,621. Such assemblies are'often referred to as IPPB manifold assembly devices and accordingly, the term manifold will be used to so designate hereinafter. The manifold is attached to the gas supply tube or tubes which deliver pressurized oxygen or oxygen containing gas from the control unit. The manifold works in cooperation with the control unit to provide for intermittent gas delivery to the patient and to allow for unobstructed expiration of the gas.
As evidenced by the devices disclosed in the aforesaid patents, prior art manifolds incorporate a number of individual parts and are thus rather complex in construction as well as having other disadvantages. Disadvantages in producing the device having a number of individual parts or components which mustbe fitted and interlocked together during manufacture and assembly are self evident. Especially, from a manufacturing standpoint, the various parts must be indivdually molded or stamped requiring a variety of dies. These individual parts then must be hand or machine assembled thereby further increasing their costs.
Not only are such manifolds undesirable from a manufacturing or production standpoint but because of the rather complex construction including plurality of fitting parts gas leakage may occur with concomitant reduction in efficiency unless the fittings are made correctly and the components properly secured. Such a plurality of component parts also lends to instances of improper assembly which, of course, requires time consuming inspection and quality control thereby increasing product costs. Moreover, because of the design of interior passageways of most prior art manifolds, pockets or crevices are present in which foreign material or bacteria may lodge. Even though the devices are made of plastic and are intended for single patient use and thereafter disposed, certain bacteria or virus may grow rapidly in a relatively short period of time. The elimination of such disadvantages is especially-important when the manifoldsare used to treat patients having lung or respiratory ailments. Moreover, where gases are required to flow through or between offset or angled passageways, air flow may be somewhat impeded and undesirable turbulence created.
Manifolds are often used in combination with a neubulizer when it is desirable to ,humidify the oxygen or oxygen containing gases administered to the patient or to create a mist or vapor of fine particles of water or medicament in the treatment of certain respiratory disorders. Certain prior art manifolds require the neubulizer to be offset from the normal gas flow. Such devices also usually create a slip-stream or internally baffled main stream gas flow in order to induce pick-up of the mist generated by the neubulizer. Such techniques do not utilize maximum nebulizer advantages and create inefficiencies because of the manner in which the nebulized particles must travel within the device prior to reaching the main oxygen flow to the patient.
Finally, there is a need for a simply designed and unifornily constructed manifold which can be easily adapted to use for either Bird or Bennett respiration control units. It is to the elimination of the above-noted disadvantages and for the production of a manifold and nebulizer assembly which can be inexpensively produced and yet be adaptable to either of the types of respiratory control devices as noted that the present invention is directed.
SUMMARY OF THE INVENTION The manifold device of the present invention is intended to obviate the disadvantages noted hereinabove. The device, excluding the nebulizer portion incorporates a minimum number of components whereby the necessity of fitting or snapping together a number of individually molded parts is not required. Thus, the cost of manufacture, assembly and inspection is significantly reduced as well as substantially eliminating possible dangers of improper assembly, leakage around fitted parts, joints and the like.
The device comprises an elongated substantially vertical main tube portion having a pair of oppositely disposed tubular ports extending substantially normal to the main tube axis. The first of said ports is for attaching a gas supply conduit from an IPPB control unit and thus receives air or oxygen enriched air from the control unit during patient inspiration. The second, and oppositely disposed port is for attaching amouthpiece or conduit directed to a mouthpiece, mask or similar dediaphragm is in sealed engagement with an exhalation valve cap and therebetwee'n is defined the diaphragm chamber. Extending from the exhalation valve cap are a pair of hollow pipes which communicate with the diaphragm chamber through orifices in the valve cap. Alternatively one pipe may be used in combination with a gas flow restricting member as will be more fully explained hereinafter.
A further embodiment includes an improved nebulizer secured to the lower end of the main manifold tube. The manifold device, in addition to having relatively few parts including the neubulizer portion extends generally along the vertical axis of the main mani fold tube. Thus, the exhalation valve assembly is located directly above and substantially coaxial to the main manifold tube while the nebulizer portion, also coaxial with the main tube is located at the lower tube end. Accordingly, the device, having only tubes and ports extending therefrom is balanced, with the center of the balance or gravity extending substantially along the main manifold tube vertical axis. This feature is important in utilizing the nebulizer whereby the medicamentor water level therein will be substantially normal to the main tube vertical axis. Other advantages as well as the operational features of the device will be more fully explained hereinafter.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a side elevational view of the manifold device of the invention partially in section to expose the interior thereof;
FIG. 2 is a bottom plan view of the exhalation valve p;
FIG. 3 is a perspective view of the device showing tube attachements used with a Bennett IPPB unit;
FIG. 4 is a perspective view of the device showing tube attachements for use with a Bird IPPB unit;
FIG. 5 is a perspective view of an alternative exhalation valve cap and gas flow restrictor as used for a Bird IPPB unit;
FIG. 6 is a top plan view of the manifold device with the exhalation valve cap removed;
FIG. 7 is a bottom plan view of the manifold device with the nebulizer assembly removed;
FIG. 8 is a perspective view of the diaphragm;
FIG. 9 is a side sectional elevation of a gas flow restrictor;
FIG. 10 illustrates the lower portion of the manifold device including a side sectional elevation of the nebulizer assembly;
FIG. 11 is an enlarged sectional elevational view of the air nozzle and aspirator cap portion of the nebulizer assembly; and
FIG. 12 is a sectional view taken along line BB of FIG. 11.
DETAILED DESCRIPTION OF THE INVENTION Referring now to FIG. 1, themanifold device 10 comprises an elongated verticalmain tube 12 which terminates at anupper end 22 andlower end 18. The tube is substantially hollow along its entire length with openings at the respective upper and lower ends 22 and 18. The main tube interior is preferably of a substantial uniform diameter between the ends. Adjacent the lower main tube end is anebulizer cap 14 which cap is secured to the main tube and preferably integral therewith. The lower portion ofmain tube 12 extends throughnebulizer cap 14 and into the cavity ofnebulizer jar 16 when the latter is attached to the cap. The cap is also preferably provided with threads for threadedly engaging the nebulizer jar.
At the upper end ofmain tube 12 is anexhalation valve assembly 24 which includes annular exhalation valve housing 25 (note FIG. 6),diaphragm 36,exhalation valve cap 28,exhalation port 38 andpipes 30 and 32 (note FIG. 2). Referring also to FIG. 6, valve housing .25 includesannular sidewall 72 extending upwardly fromvalve housing base 74. A normally extendingflange 76 is preferably formed around at the upper end ofsidewall 72, the upper surface of which flange provides a seat for seating engagement with a diaphragm as will be pointed out hereinafter. It will be noted that an upper portion of the manifold main tube extends into a valve housing cavity defined within the valve housing which cavity has a greater diameter than the main tube. However, the shape and size of the exhalation valve housing is not critical so long as it accomodates the upper portion of the main manifold tube, the diaphragm and valve cap. Atubular exhalation port 38 is also secured to and extends fromvalve housing 25 so that the exhalation port communicates with the valve housing cavity throughwall 72.Valve housing 25 includingsidewall 72,base 74 andexhalation port 38 are also preferably integrally molded 'with the main tube.
Referring also to FIG. 2,exhalation valve cap 28, provides a closure for the exhalation valve assembly. The valve cap includes a pair ofhollow pipes 30 and 32 which communicate with channel or groove 31 formed in the cap which in turn is exposed to a diaphragm chamber. The valve cap also includes anannular skirt 34 which is designed to fit over and engageflange 76 at the upper circumferential end ofvalve housing sidewall 72. At the top ofvalve cap 28 is aball member 40 used to suspend the manifold device from a socket or clamp of supporting apparatus.
Referring also to FIG. 8,diaphragm 36 comprises a cup-shpaed flexible gas impermeable membrane having a substantiallyflat base surface 21,sidewall 33 and an upperannular flange 15 which rests onannular flange 76 of the exhalation valve housing. Thus, whencap 28 is secured to flange 76 it forcesdiaphragm flange 15 into. sealed engagement therebetween.Diaphragm chamber 26 is defined within the diaphragm cup and exhalation valve cap and communicates withpipes 30 and 32. The diaphragm chamber is alternately pressurized by introducing gas via the pipes whereby the diaphragm expands and because of its close proximity to uppermain tube end 22,flat base 21 is forced downwardly sealing off the upper main tube opening. When the diaphragm is not in an expanded state its base may rest lightly on the upper main tube end or be only slightly separated therefrom so that expired gases may pass therebetween.
Extending fromexhalation valve assembly 25 isexhalation port 38. The exhalation port is in communication with the interior cavity defined byvalve housing 25 so that when diaphragm 36.is not expanded, expired gas from a patient passing into the main tube may pass through upper main tube opening and exit throughexhalation port 38.
Downwardly from the exhalation valve assembly alongmain tube 12 and extending therefrom are a pair oftubular ports 35 and 37. These ports may be conveniently located approximately midway between the upper and lower main tube ends.First port 35 directs air or oxygen enriched air intomain tube 12 andsecond port 37 directs the gas to a patient frommain tube 12 andreceives expired patient gases. Because of these functions,ports 35 and 37 are preferably oppositely disposed on the main tube and extend normal to vertical main tube axis as shown.
Attached to the lower portion ofmain tube 12 is a nebulizer assembly including anebulizer cap 14 andjar 16. The nebulizer assembly, which will be described in more detail hereinafter is for the purpose of creating and directing a mist or aerosol of finely nebulized water or medicament particles intomain tube 12 throughlower tube end 18 during patient inspiration. The aerosol is forced upwardly along the lower portion of the main tube where it mixes with air or oxygen enriched air flowing across the main tube interior fromport 35 toport 37 and to the patient.
Noting FIGS. 1 and 10,nebulizer cap 14 includes a flattop portion 17 extending radially from a lower portion of mainmanifold tube 12 whereby the latter projects downwardly for a distance past the plane of intersection and into the nebulizer jar cavity. Anannular skirt 39 extends circumferentially from flattop portion 17 and the inner skirt surface is preferably provided with threads for theadedly engagingnebulizer jar 16. The nebulizer cap is preferably integrally molded tomain tube 12.
Basically, and referring especially to FIG. 1, the principal of operation of the manifold device of the invention is as follows;
On patient inspiration, air or oxygen enriched air is passed from a respirator or IPPB control unit intofirst port 35, across the central interior ofmain tube 12 and throughsecond port 37 which is connected by a suitable gas directing conduit such as a flexible hose and mask or mouthpiece to a patient. At the same time, gas is forced into the nebulizer through a separate conduit creating an aerosol which is directed upwardly through lowermain tube opening 18 andmain tube 12 where it combines with the flow of gas passing across the main tube fromport 35 toport 37. Concurrently,diaphragm chamber 26 is pressurized by gas supplied through exhalationvalve cap pipe 30 expandingdiaphragm 36 and sealing theupper end 22 ofmain tube 12. Thus, the diaphragm sea] at the upper main tube end prevents air or oxygen withinmain tube 12 from leaking during patient inspiration.
As the patients lungs become filled with the gas and inspiration is terminated, a flow sensing means in an IPPB control unit shuts off the air flow toport 35,diaphragm chamber 26 and to the nebulizer. The pressure in the diaphragm chamber is then dumped wherebydiaphragm 36 returns to an unexpanded position. As this occurs, the seal at upper main tube opening 22 is relieved and the patient exhales, expired gases are directed throughport 37, upwardly through the upper portion of themain tube 12, out through upper mainupper tube opening 22 andexhalation port 38. Expired air is normally not allowed to pass into the nebulizer jar either when the nebulizer is connected for nebulization or when it is sealed off. However, expired patient gases normally may not pass back throughport 35 or into the nebulizer through the main tube becuase of static pressures.
Referring now to FIGS. 3 and 4, there are shown two different means for connecting the manifold device of the invention, FIG. 3 illustrating the manner for connecting the unit to a Bennett IPPB control unit, and FIG. 4 for connection to a Bird unit. Referring first to FIGS. 1 and 3,line 50 is connected between a Bennett IPPB unit (not shown) andexhalation valve pipe 30. It
will be noted thatsecond pipe 32 is sealed off bycap 48 so that only one of the pipes is utilized in the Bennett mode.Nebulizer supply line 56 is attached viahose connector 61 between nebulizer l6 and to a nebulizer gas pressure outlet on the Bennett unit. A largerflexible supply conduit 20 is attached between the Bennett device and mainoxygen inlet port 35. Thesecond port 37 is attached to mouthpiece 23 for delivery of the oxygen enriched gas to a patient.
In operation, during patient inspiration the Bennett unit will supply air or oxygen'enriched air to the nebulizer throughsupply line 56, at a constant pressure, usually between about 40 psi and about 60 psi during inspiration. At the same time, the Bennett unit supplies gas under pressure viacontrol line 50 topipe 30 and intodiaphragm chamber 26 thereby expandingdiaphragm 36 to seal off uppermain tube end 22 of the manifold. Oxygen or oxygen enriched gas to be inhaled by the patient is supplied byconduit 20 viaports 35 and 37. Again, it will be appreciated that during patient inspiration as the pressure is continuously being supplied to the nebulizer vialine 56, fine medicament or water particles in the form of an aerosol are combined and mixed with gas inmain tube 12 and directed to the patient.
As the patients lungs become filled and he begins to exhale the pressure change will be sensed by the Bennett unit and gas flow is terminated. Gas pressure in the diaphragm chamber is dumped by the control unit viapipe 30 andcontrol line 50 and oxygen supplied to the nebulizer andport 35 ceases. As pressure within the diaphragm chamber is relieved the diaphragm no longer seals the opening atupper end 22 ofmain tube 12. Accordingly, expired gases will pass throughtube 21,port 37, intomain tube 12, upwardly throughmain tube 12 and out throughend 22 andexhalation port 38.
FIG. 4 illustrates the manifold device as it is used with a Bird IPPB unit. It will be noted thatpipe 32 is not capped but instead communicates withnebulizer 16 viasupply line 58. Because a Bird respirator is a single line-type, it does not have a separate nebulizer gas pressure supply line. Thus, when using a Bird unit gas to the nebulizer is supplied through the diaphragm chamber. Referring also to FIG. 1, gas from the unit (not shown) is directed viasupply line 50 andpipe 30 intodiaphragm chamber 26. Again, this causes the diaphragm to expand and seal offupper end 22 of mainmanifold tube 12. Gas supplied by the Bird unit to the diaphragm chamber viasupply line 50, during patient inspiration, will normally be constant, for example, about 50 psi. Since that amount of pressure is in excess of that required to maintain the diaphragm seal, the excess gas is directed to the nebulizer viapipe 32 andconduit 58. Moreover, the diameter ofpipe 32 is preferably larger thanpipe 30 so as to ensure sufficient venting of gas from the diaphragm chamber to the nebulizer and preventing undue diaphragm chamber pressure which could rupture the diaphragm.
Upon termination of patient inspiration and during expiration, the flow of gas into the diaphragm chamber vialine 50 is terminated thereby allowing pressure in the chamber to be dumped. For this purpose, anorifice 29 of suitable diameter is present inconduit 58 through which diaphragm chamber pressure will be dumped once the gas flow insupply line 50 is terminated. The size or diameter oforifice 29 will be large enough to permit rapid pressure dumping and yet small enough to allow sufficient gas to be directed to the nebulizer through the supply line during patient inspiration. It will also be understood that once the diaphragm pressure is dumped through the orifice, gas fiow to the neubulizer is then also terminated. Otherwise, the manifold assembly as shown in FIG. 4 operates similar to that as shown in FIG. 3.
Observing again FIG. 3, in the Bennett mode of operation,cap 48 is provided to sealpipe 32 which is not used. Where the pipes are of different sizes, both internally and externally,cap 48 will fitonly pipe 32 which reduces the chances of an operator inadvertently sealing offpipe 30. Such a feature is thus convenient and will reduce the possibility of an inexperienced operator incorrectly making the attachments when used in the Bennett mode.
An alternative embodiment of the exhalation valve cap described hereinabove is shown in FIG. utilizingvalve cap 75 having asingle pipe 78 corresponding topipe 30 previously described and which pipe communicates with the diaphragm chamber. Thus, in the Bennett mode in which only one pipe is utilized, this embodiment will be used and functions substantially as described according to FIG. 3 but eliminating the requirement of capping a second pipe.
Where the single pipe embodiment is to be used with a Bird unit it will be necessary to attach a gas flow restricting and splittingmember 70 which will be referred to as a T-adapter hereinafter. Referring also to FIG. 9, the T-adapter provides a triple function required for adapting the unit for Bird mode operation. The T adapter includes three gas directing ports.Port 71 is attached to control line 50-which directs gas flow from the Bird unit.Port 75 is secured directly topipe 30 for directing the flow of gas into the diaphragm chamber whileport 72 is secured tonebulizer supply line 58 which does not have an orifice as does supplyline 58. T-adapter 70 also incorporatesrestrictor wall 77 having anorifice 73 therein for reducing the gas pressure supplied into the manifold diaphragm chamber. Thus,orifice 73 will allow a majority of gas supplied to flow throughport 72 to operate the nebulizer and yet sufficient gas to enter the diaphragm chamber and expand the diaphragm for sealing the upper end of the main manifold tube during patient inspiration. Adump vent 74 is located on the low pressure side ofrestrictor wall 77 for venting or relieving gas pressure in the diaphragm chamber when the gas flow from the Bird unit is terminated during patient expiration and for controlled leakage preventing unduly high diaphragm pressure buildup during patient inspiration. Thus, dumpvent 74 functionally corresponds to orifice 29 innebulizer supply line 58 in the embodiment shown in FIG.
For normal Bird unit operation where pressure supplied throughcontrol line 50 is about 50 psi, suitable diameters oforifice 73 are between about 0.015 and about 0.025 inch and vent 74 between about 0.030 and about 0.035 inch and more preferably about 0.019 and about 0.031, respectively.
Alternatively, the T-adapter may be used with the two pipe embodiment shown in FIG. 4 for the Bird mode. However, only one pipe will be used with the other pipe closed off or capped and eliminating the need forsupply line 58 havingorifice 29. Thus, the attachments used will corrresppnd to those shown in FIG. 5 with T-adapter 70 attached topipe 30 whilepipe 32 will be capped (see FIG. 3).
In still a further embodiment to be used with the Bird unit and referring to FIG. 4,orifice 29 insupply line 58 may be eliminated and instead a dump port may be provided on the exhalation valve cap. However, in order to further restrict unduly great pressure in the diaphragm chamber a separator disc may be placed between the valve cap and diaphragm which disc is provided with a restricting orifice. Thus, the combined orifices and separator disc will achieve the same function of the T-adapter previously described it being understood that such functions are required for use in the Bird mode.
Referring again to FIG. 1, it will be noted that the manifold of the invention is quite symmetrical since all of the ports as well as the exhalation valve assembly and nebulizer components are not substantially displaced or offset from the longituidinal axis ofmain tube 12. This construction offers advantages over previous manifold devices. For example, because of the symmetry of the manifold and its components, when the device is attached to a holding arm which fits aroundball member 40, because of its center of gravity along the vertical axis the manifold will remain substantially upright rather than at an angle relative to vertical. Such a feature will insure that the water or medicament level within the nebulizer will be at least nearly normal to the vertical manifold axis since the nebulizer jar will not be tipped which, if the water or medicament level was low, could cause nebulizer inefficiency or malfunction. In addition, as a mist is generated by the nebulizer it will be forced upwardly directly into themain manifold tube 12 without passing through any offset chambers or angled ports prior to being mixed with oxygen which passes across the flow of mist and is directly mixed with the aerosol. That feature is also designed to optimize the functions of the device thereby achieving maximum efficiency. Such features, combined with the relative simplicity of construction of the device including minimum number of parts provides not only reduced construction and assembly costs but the other advantages as noted hereinabove over prior art devices as will be appreciated by those skilled in the art.
Expired gases passing fromexhalation port 38 may be directed to a gas analyzer or similar device for measuring the amount or composition of the expired gas as desired. Thus, if carbon dioxide concentration, vital capacity or other tests are desired, a suitable conduit may be attached toexhalation port 38 for directing the gases to the analyzing equipment. Otherwise, the expired gas will simply be directed to the room atmosphere. Further an exhalation retard cap for adjusting exhalation rates may be attached to the exhalation port.
Referring now to FIGS. 10-12, the improved nebulizer of the invention is situated directly below themain tube 12 along its vertical axis.Nebulizer jar 16 is attached to cap 14 which is affixed to the lower end ofmain tube 12 as shown. The method of attachment of the jar to the cap is not critical and it may be snapped into place or the interior ofskirt 39 and the top exterior side of the jar may be provided threads for threadedly engaging the two parts as shown in FIG. 1. The shape of the jar is not particularly critical but it is preferred that it has a bowl-shapedbottom 62 for improved efficiency as will be explained hereinafter.
Extending upwardly from bottom 62 and integral therewith is anair nozzle 44. Preferably, the air nozzle and bowl-shaped bottom are molded as a portion of the nebulizer jar. It will be noted thatnozzle 44 is elongated and has aninterior nozzle cavity 43 through which gas is upwardly directed. The nozzle terminates at its apex in anozzle orifice 49 located along the central vertical axis of the nozzle. The sides ofnozzle 44 are also preferably inclined or slanted inwardly from the bottom to top so that the diameter of both the interior and exterior nozzle surface decreases from bottom to top. Ahose connector 61 integral withair nozzle 44 extends below bottom 62 for attaching asupply line 52.
However, the design of the exterior bottom portion of the nebulizer jar is not critical and may be as shown or otherwise modified, so long as means for providing air to the air nozzle is present to achieve the desired purpose.
Anaspirator cap 42 is disposed coaxially on the air nozzle as shown and substantially covers the air nozzle.Bottom edge 55 ofaspirator 42 does not rest on thebottom surface 62 ofjar 16 but instead is elevated therefrom somewhat to provide a passageway for water or medicament within the nebulizer chamber defined within the nebulizer jar. Alternatively, the aspirator cap end may rest on or be secured to the bowl surface with passageways formed through and along its lower end. At the upper end of ofaspirator cap 42 is anorifice 47 which is disposed directly in line aboveorifice 49 ofair nozzle 44. The top surface of both the air nozzle and aspirator cap may be flattened in the form of a flange having the respective orifices therein as shown for the air nozzle or one or both may be formed like that of the aspirator cap (see FIG. 11).
Observing particularly FIG. 12, there is illustrated the relationship ofaspirator cap 42 andair nozzle 44 whereby the interior sides of the aspirator cap are cut so that a portion of the interior sides rest against the exterior side surface of the air nozzle. It will be noted that the interior sides ofaspirator cap 42 are beveled to provide a plurality ofchannels 53 between the exterior air nozzle surface and interior aspirator cap surface. Alternatively the interior aspirator cap surface may be circumferential and the exterior air nozzle surface beveled to provide the channels. The channels are in communication with the space betweenbottom edge 55 ofaspirator cap 42 and bottom 62 of the nebulizer jar, so that water or medicament can flow into the aforesaid space and is drawn up through the channels to mixing chamber 51 (see FIG. 11). Mixingchamber 51 is defined as the space betweenair nozzle orifice 49 andaspirator cap orifice 47 as shown in FIG. 11.
In operation, with water or medicament placed in thenebulizer jar 16, air or oxygen enriched air is supplied viasupply line 52 into the interior ofnozzle 44 where it is forced out ofnozzle orifice 49. Depending on the liquid surface tension, water or medicament will usually rise withinchannels 53 by capillary action thereby pre-priming the system and improving its response time to inspiratory gas flow. Because of the lower pressure provided in mixingchamber 51 by the jets stream of air escaping fromnozzle 49, through the mixing chamber and out throughaspirator cap orifice 47, liquid withinchannels 53 will be drawn upwardlytherealong mixing chamber 51. The liquid is drawn into the mixing chamber due to the partial vacuum created therein by the gas being forced therethrough which partial pressure is lower than the pressure on the surface of the liquid within the nebulizer jar and is often referred to as the Venturi principle as will be appreciated by those skilled in the art. Further, as the gas escaping fromnozzle orifice 49 contacts and mixes with the liquid within mixingchamber 51, because of the gas velocity, small droplets of the wateror medicament will be formed in the form of an aerosol or mist which will pass through restrictedaspirator cap orifice 47. Thereafter, observing further FIG. 10, the mist will impinge on the lower surface ofbaffle 46 located directly aboveaspirator cap orifice 47 and spaced therefrom and then be deflected out into theinterior chamber 45 of the nebulizer..
It will be noted that the liquid level withinjar 16 should be maintained below the horizontal plane ofair nozzle orifice 49. Should the liquid level be too high, the liquid level within the channels would spill over the top ofnozzle orifice 49, drain into the interior of the air nozzle and into the oxygen orgas directing tube 52 which is undesirable. For this purpose, a visible maxi mum liquid level line or indicia may be scribed or molded onjar 16 for observation by an operator to prevent filling the jar with too much water or medicament. Further, since the manifold device of the invention including the nebulizer jar are maintained along a substantially vertical plane, even when in operation because of the devices symmetry, the liquid level can be readily observed by an operator whereas in other devices which are unbalanced and tilted with respect to vertical, the liquid surface level may not be so correctly observed relative to the scribed line on the nebulizer Although abaffle 46 is optional, it will be preferred since it assists further nebulization of the liquid particles impinging thereon. Moreover, it will prevent unduly large particles from enteringmain tube 12 of the manifold. Generally for most patients receiving inhalation therapy requiring a mist or aerosol composed of fine droplets of water or medicament in an air or oxygen enriched air stream, particle sizes between about 2 and about 5 microns are preferred. Thus, by using a baffle in cooperation with the spray orifice, larger particles will be further broken up as they impinge against the baffle surface or will collect there. Such particles or drops are then forced outwardly from the surface by the forced gas and fall into the body of water or medicament within the jar.
As shown, baffle 46 comprises a main body having extending downwardly therefrom a plurality ofarms 40 which are flanged on the bottom. Theflanged portion 59 extends inwardly and is connected or attached to the exterior side ofaspirator cap 42. However, such construction is not particularly critical and other means of employing a baffle and attaching it within the nebulizer chamber may be used. However, again, the baffle is preferably located so that the surface on which the nebulized mist is forced fromaspirator cap orifice 47 will impinge is located directly above but separated from'that orifice.
Observing again FIG. 12,aspirator cap 42 is shown as having its interior side out to provide four flattened surfaces which rest against the circumferential exterior surface ofair nozzle 44. However, any number of such flattened surfaces may be formed on the interior surface of theaspirator cap 42 to achieve the same purpose and provide a like number of passageways for flow of the medicament or liquid.
It has been found that the relationship of the relative sizes of the air nozzle orifice and aspirator cap orifice as well as the distance therebetween is an important feature of the invention to achieve optimum aerosol characteristics. To achieve particles sizes within the preferred range of between about 2 and about 5 microns it has been found that the air nozzle orifice and aspirator cap orifice should have diameters between 0.030 and 0.032 and 0.041 and 0.043 inch respectively. In addition, the distance between the upper edge of the air nozzle orifice and lower edge of the aspirator cap nozzle should be greater than the diameter of either of the orifices and preferably about two times greater than the diameter of the aspirator cap orifice. Although the improved nebulizer is described herein for uses with the manifold it should be appreciated that it may be used to provide an aerosol for other inhalation therapy equipment such as oxygen masks, mouthpieces and the like.
Various types of materials and preferably plastics may be used to prepare the device of the invention. For example, the main manifold tube and exhalation valve assembly may be formed of high impact polystyrene, polyethylene and similar materials where visibility through the parts is not critical. The nebulizer cap may also be prepared of the same material. However, the nebulizer jar should preferably be made of a clear plastic such as crystal styrene.
I claim:
1. An IPPB manifold device for use with an IPPB respirator of either of two types, type (i) providing a main stream of gas and two minor gas streams during patient inspiration and type (ii) providing a main stream of gas and one minor gas stream during patient inspiration, the manifold comprising:
a. a hollow main tube being elongated along a vertical axis and terminating at openings at both the upper and lower tube ends;
b. a nebulizer attached to the lower end of said main tube said nebulizer comprising an air nozzle provided with gas inlet means and having an upper orifice and an aspirator cap provided with liquid inlet means and having an upper orifice said air nozzle and aspirator cap orifices being coaxially aligned with said main tube whereby aerosol emanating from said aspirator cap orifice is directed upwardly toward said lower tube opening and into said main tube;
c. a diaphragm for alternately closing the upper main tube opening and in sealing engagement with an upper cap portion having an air supply conduit means and wherein said cap and diaphragm define a gas pressure chamber therebetween with which chamber the conduit means communicates said conduit means comprising first and second pipes, whereby in use with said type (i) respirator a first gas supply tube is attached between the first pipe and said respirator for delivering one of said minor gas streams to said pressure chamber and said second pipe is stoppered, and a second gas supply tube is attached between said respirator and said nebulizer for delivering the other of said minor gas streams thereto, and in use with said type (ii) respi rator a third gas supply tube is attached between the first one of said pipes and said respirator for delivering the minor gas stream to said pressure chamber and a fourth gas supply tube is attached between said second pipe and said nebulizer for directing a portion of said minor gas stream from said chamber thereto;
(1. a walled housing member for receiving said diaphragm having a lower end radially extending from and secured to said main tube adjacent the upper tube end and having and upper rim to which said upper cap is secured;
e. an exhalation port adjacent said upper main tube end and extending through said walled housing member; and
f. a tubular gas inlet port and a tubular gas outlet port oppositely disposed along said main tube and extending normal to the vertical axis thereof between said upper and lower main tube ends wherein a gas supply hose is attached between said respirator and said gas inlet port for delivering said main stream of gas to said device and from said gas outlet port to a patient, whereby said main gas stream flowing from said gas inlet port to said outlet port passes across said main tube where it is combined with said aerosol.
2. The device of claim 1 wherein said diaphragm includes a flange therearound which flange is sealingly engaged between said upper cap and the upper rim of said walled housing member.
3. The device of claim 1 wherein said nebulizer further comprises a jar portion having sides, bottom and top defining a nebulizing chamber, said aspirator cap being coaxially mounted on said air nozzle, said air and aspirator cap orifices being spaced apart to define an aspirating chamber therebetween and wherein the distance between said aspirator cap orifice and said air nozzle orifice is greater than the diameter of either of said orifices.
4. The device of claim 3 whereinthe diameter of said air nozzle orifice is smaller than the diameter of said aspirator cap orifice.
5. The nebulizer of claim 4 including a baffle axially disposed adjacent said aspirator cap orifice.
6. An IPPB manifold device for use with an IPPB respirator of either of two types, type (i) providing a main stream of gas and two minor gas streams during patient inspiration and type (ii) providing a main stream of gas and one minor gas stream during patient inspiration, the manifold comprising:
a. a hollow main tube being elongated along a vertical axis andterminating at openings at both the upper and lower tube ends;
b. a nebulizer attached to the lower end of said main tube said nebulizer comprising an air nozzle provided with gas inlet means and having an upper orifice and an-aspirator cap provided with liquid inlet means and having an upper orifice said air nozzle and aspirator cap orifices being coaxially aligned with said main tube whereby aerosol emanating from said aspirator cap orifice is directed upwardly toward said lower tube opening and into said main tube;
0. a diaphragm for alternately closing the upper main tube opening and in sealing engagement with an upper cap portion having a single air supply pipe and wherein said cap and diaphragm define a gas pressure chamber therebetween said pipe communiating therewith whereby in use with said type (i) respirator a first gas supply tube is attached between said pipe and said respirator for delivery of one of said minor gas streams to said pressure chamber and a second gas supply tube is attached between said respirator and said nebulizer for delivering the other of said minor gas streams thereto, and in use with said type (ii) respirator said device includes a gas flow restricting and splitting member having an air inlet for receiving said minor gas stream from said respirator, and first and second gas outlets, the first outlet being attached to said pipe for supplying a portion of' said minor gas stream to said pressure chamber and the second outlet for supplying a portion of said minor gas stream to said nebulizer;
d. a walled housing member for receiving said diaphragm having a lower end radially extending from and secured to said main tube adjacent the upper tube end and having an upper rim to which said uppercap is secured;
e. an exhalation port adjacent said upper main tube end and extending through said walled housing member; and
f. a tubular gas inlet port and a tubular gas outlet port oppositely disposed along said main tube and extending normal to the vertical axis thereof between said upper and lower main tube ends wherein a gas supply hose is attached between said respirator and a 14 said gas inlet port for delivering said main stream of gas to said device and from said gas outlet port to a patient, whereby said main gas stream flowing from said gas inlet port to said outlet port passes across said main tube where it is combined with said aerosol.
7. The device of claim 6 wherein said diaphragm includes a flange therearound which flange is sealingly engaged between said upper cap and the upper rim of said walled housing member.
8. The device of claim 6 wherein said nebulizer further comprises a jar portion having sides, bottom and top defining a nebulizing chamber, said aspirator cap being coaxially mounted on said air nozzle, said air and aspirator cap orifices being spaced apart to define an aspirating chamber therebetween and wherein the distance between said aspirator cap orifice and said air nozzle orifice is greater than the diameter of either of said orifices.
9. The device of claim 8 wherein the diameter of said air nozzle orifice is smaller than the diameter of said aspirator cap orifice.
10. The nebulizer of claim 9 including a baffle axially disposed adjacent said aspirator cap orifice.

Claims (10)

1. An IPPB manifold device for use with an IPPB respirator of either of two types, type (i) providing a main stream of gas and two minor gas streams during patient inspiration and type (ii) providing a main stream of gas and one minor gas stream during patient inspiration, the manifold comprising: a. a hollow main tube being elongated along a vertical axis and terminating at openings at both the upper and lower tube ends; b. a nebulizer attached to the lower end of said main tube said nebulizer comprising an air nozzle provided with gas inlet means and having an upper orifice and an aspirator cap provided with liquid inlet means and having an upper orifice said air nozzle and aspirator cap orifices being coaxially aligned with said main tube whereby aerosol emanating from said aspirator cap orifice is directed upwardly toward said lower tube opening and into said main tube; c. a diaphragm for alternately closing the upper main tube opening and in sealing engagement with an upper cap portion having an air supply conduit means and wherein said cap and diaphragm define a gas pressure chamber therebetween with which chamber the conduit means communicates said conduit means comprising first and second pipes, whereby in use with said type (i) respirator a first gas supply tube is attached between the first pipe and said respirator for delivering one of said minor gas streams to said pressure chamber and said second pipe is stoppered, and a second gas supply tube is attached between said respirator and said nebulizer for delivering the other of said minor gas streams thereto, and in use with said type (ii) respirator a third gas supply tube is attached between the first one of said pipes and said respirator for delivering the minor gas stream to said pressure chamber and a fourth gas supply tube is attached between said second pipe and said nebulizer for directing a portion of said minor gas stream from said chamber thereto; d. a walled housing member for receiving said diaphragm having a lower end radially extending from and secured to said main tube adjacent the upper tube end and having and upper rim to which said upper cap is secured; e. an exhalation port adjacent said upper main tube end and extending through said walled housing member; and f. a tubular gas inlet port and a tubular gas outlet port oppositely disposed along said main tube and extending normal to the vertical axis Thereof between said upper and lower main tube ends wherein a gas supply hose is attached between said respirator and said gas inlet port for delivering said main stream of gas to said device and from said gas outlet port to a patient, whereby said main gas stream flowing from said gas inlet port to said outlet port passes across said main tube where it is combined with said aerosol.
6. An IPPB manifold device for use with an IPPB respirator of either of two types, type (i) providing a main stream of gas and two minor gas streams during patient inspiration and type (ii) providing a main stream of gas and one minor gas stream during patient inspiration, the manifold comprising: a. a hollow main tube being elongated along a vertical axis and terminating at openings at both the upper and lower tube ends; b. a nebulizer attached to the lower end of said main tube said nebulizer comprising an air nozzle provided with gas inlet means and having an upper orifice and an aspirator cap provided with liquid inlet means and having an upper orifice said air nozzle and aspirator cap orifices being coaxially aligned with said main tube whereby aerosol emanating from said aspirator cap orifice is directed upwardly toward said lower tube opening and into said main tube; c. a diaphragm for alternately closing the upper main tube opening and in sealing engagement with an upper cap portion having a single air supply pipe and wherein said cap and diaphragm define a gas pressure chamber therebetween said pipe communiating therewith whereby in use with said type (i) respirator a first gas supply tube is attached between said pipe and said respirator for delivery of one of said minor gas streams to said pressure chamber and a second gas supply tube is attached between said respirator and said nebulizer for delivering the other of said minor gas streams thereto, and in use with said type (ii) respirator said device includes a gas flow restricting and splitting member having an air inlet for receiving said minor gas stream from said respirator, and first and second gas outlets, the first outlet being attached to said pipe for supplying a portion of said minor gas stream to said pressure chamber and the second outlet for supplying a portion of said minor gas stream to said nebulizer; d. a walled housing member for receiving said diaphragm having a lower end radially extending from and secured to said main tube adjacent the upper tube end and having an upper rim to which said upper cap is secured; e. an exhalation port adjacent said upper main tube end and extending through said walled housing member; and f. a tubular gas inlet port and a tubular gas outlet port oppositely disposed along said main tube and extending normal to the vertical axis thereof between said upper and lower main tube ends wherein a gas supply hose is attached between said respirator and said gas inlet port for delivering said main stream of gas to said device and from said gas outlet port to a patient, whereby said main gas stream flowing from said gas inlet port to said outlet port passes across said main tube where it is combined with saId aerosol.
US00265390A1972-06-221972-06-22Intermittent positive pressure breathing manifoldExpired - LifetimeUS3826255A (en)

Priority Applications (13)

Application NumberPriority DateFiling DateTitle
US00265390AUS3826255A (en)1972-06-221972-06-22Intermittent positive pressure breathing manifold
CA173,136ACA1003292A (en)1972-06-221973-06-04Intermittent positive pressure breathing manifold
GB5159574AGB1431082A (en)1972-06-221973-06-05Intermittent positive pressure breathing manifold
GB2685873AGB1431081A (en)1972-06-221973-06-05Internittent positive pressure breathing manifold
ZA733952AZA733952B (en)1972-06-221973-06-12Intermittent positive pressure breathing manifold
NL7308327ANL7308327A (en)1972-06-221973-06-15
AU57048/73AAU468299B2 (en)1972-06-221973-06-18Intermittent positive pressure breathing manifold
SE7308763ASE402865B (en)1972-06-221973-06-20 BRANCH RUBBER DEVICE FOR USE BY A RESPIRATOR AND IN TOGETHER WITH FOG FORM
DE2331525ADE2331525C3 (en)1972-06-221973-06-20 Distributor and valve housings for ventilators
NO2577/73ANO135345C (en)1972-06-221973-06-21 BRANCH DEVICE FOR USE WITH A RESPIRATOR.
BE132521ABE801216A (en)1972-06-221973-06-21 DISTRIBUTOR FOR A BREATHING DEVICE
JP48070402AJPS5131480B2 (en)1972-06-221973-06-21
JP49093770AJPS5239277B2 (en)1972-06-221974-08-15

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US00265390AUS3826255A (en)1972-06-221972-06-22Intermittent positive pressure breathing manifold

Publications (1)

Publication NumberPublication Date
US3826255Atrue US3826255A (en)1974-07-30

Family

ID=23010246

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US00265390AExpired - LifetimeUS3826255A (en)1972-06-221972-06-22Intermittent positive pressure breathing manifold

Country Status (11)

CountryLink
US (1)US3826255A (en)
JP (2)JPS5131480B2 (en)
AU (1)AU468299B2 (en)
BE (1)BE801216A (en)
CA (1)CA1003292A (en)
DE (1)DE2331525C3 (en)
GB (2)GB1431082A (en)
NL (1)NL7308327A (en)
NO (1)NO135345C (en)
SE (1)SE402865B (en)
ZA (1)ZA733952B (en)

Cited By (94)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3903884A (en)*1973-08-151975-09-09Becton Dickinson CoManifold nebulizer system
US3915386A (en)*1975-02-251975-10-28Respiratory CareNebulizer
US3940064A (en)*1974-08-191976-02-24Kentaro TakaokaAtomizing equipments for anesthetic liquid compounds
USD245540S (en)*1975-11-261977-08-23Arbrook, Inc.Nebulizer bag
USD245539S (en)*1975-11-261977-08-23Arbrook, Inc.Nebulizer-humidifier bag assembly
US4198969A (en)*1978-10-061980-04-22Baxter Travenol Laboratories, Inc.Suction-operated nebulizer
DE2947363A1 (en)*1978-11-291980-06-19Bard Inc C R EXHALATION VALVE
US4210155A (en)*1978-08-031980-07-01Jerry GrimesInspirational inhalation spirometer apparatus
US4251033A (en)*1978-06-121981-02-17Eastfield CorporationMist generating structure and molding apparatus therefor
US4253468A (en)*1978-08-141981-03-03Steven LehmbeckNebulizer attachment
US4333450A (en)*1976-12-141982-06-08Lester Victor ENebulizer-manifold
US4343304A (en)*1980-07-171982-08-10Hickmann Horst RVeterinary inhalation therapy apparatus
US4456179A (en)*1978-04-281984-06-26Eastfield CorporationMist generator and housing therefor
US4462397A (en)*1981-04-031984-07-31Terumo CorporationBreathing circuit
US4471773A (en)*1981-11-191984-09-18Bunnell Life System, Inc.Apparatus and method for delivering medication to patient's respiratory system
US4512341A (en)*1982-11-221985-04-23Lester Victor ENebulizer with capillary feed
DE3341711A1 (en)*1983-11-181985-05-30Drägerwerk AG, 2400 Lübeck CONTROLLABLE DIAPHRAGM VALVE FOR VENTILATORS
US4560519A (en)*1983-06-031985-12-24Respiratory Care, Inc.Self-contained nebulizer and system
US4566451A (en)*1982-07-021986-01-28Plantorgan Werk Heinrich G. E. Christensen KgVapor inhalation device
USRE32553E (en)*1978-11-291987-12-08Exhalation valve assembly
US5020532A (en)*1988-11-141991-06-04Baxter International Inc.Exhalation valve for respiratory circuit
US5027809A (en)*1990-05-171991-07-02Robinson Pat D"Peeper" performance hand held nebuilizer attachment with adjustability of expiratory pressures and expiratory restriction
USRE33642E (en)*1982-11-221991-07-23Hudson Oxygen Therapy Sales CompanyNebulizer with capillary feed
US5062419A (en)*1991-01-071991-11-05Rider Donald LNebulizer with valved "T" assembly
US5235969A (en)*1990-08-201993-08-17Intersurgical (Guernsey) LimitedNebulizer having combined structure for removing particles over two microns
US5301663A (en)*1991-07-161994-04-12Healthscan Products, Inc.Aerosol delivery system
US5570682A (en)*1993-12-141996-11-05Ethex International, Inc.Passive inspiratory nebulizer system
US5611332A (en)*1995-03-221997-03-18Bono; MichaelAerosol inhalation device containing a rain-off chamber
US5641662A (en)*1991-12-171997-06-24The Regents Of The University Of CaliforniaTransfection of lung via aerosolized transgene delivery
US5756353A (en)*1991-12-171998-05-26The Regents Of The University Of CaliforniaExpression of cloned genes in the lung by aerosol-and liposome-based delivery
US5827703A (en)*1992-06-041998-10-27The Regents Of The University Of CaliforniaMethods and composition for in vivo gene therapy
US6001644A (en)*1991-12-171999-12-14The Regents Of The University Of CaliforniaMammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US6044841A (en)*1997-08-292000-04-041263152 Ontario Inc.Breath actuated nebulizer with valve assembly having a relief piston
US6314609B1 (en)*2000-02-072001-11-13Connie GeorgeMouth powered vacuum
US6328030B1 (en)*1999-03-122001-12-11Daniel E. KidwellNebulizer for ventilation system
US6363932B1 (en)2000-07-062002-04-02Clinical Technologies, Inc.Aerosol enhancement device
US20020121275A1 (en)*2000-07-062002-09-05Clinical Technologies, Inc.Aerosol enhancement device
US20020157663A1 (en)*2001-03-202002-10-31Rick BlackerNebulizer apparatus and method
US20030037785A1 (en)*2001-06-012003-02-27Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy apparatus having a valve for limiting the inspiration flow
US20030136399A1 (en)*2001-12-212003-07-24Foley Martin P.Nebulizer apparatus and method
US6612303B1 (en)1996-02-132003-09-021263152 Ontario Inc.Nebulizer apparatus and method
US6627615B1 (en)1991-12-172003-09-30The Regents Of The University Of CaliforniaMethods and compositions for in vivo gene therapy
US6631721B1 (en)*1998-11-062003-10-14Salter LabsNebulizer mouthpiece and accessories
US20040031485A1 (en)*2002-08-192004-02-19Andre RustadSmall volume nebulizer
US6718979B1 (en)2000-06-052004-04-13Dhd Healthcare CorporationOxygen mask assembly
US6806084B1 (en)1992-06-042004-10-19The Regents Of The University Of CaliforniaMethods for compositions for in vivo gene delivery
US20050081844A1 (en)*2003-08-132005-04-21Jerry GrychowskiNubulizer apparatus and method
US20050252509A1 (en)*2004-05-142005-11-17Andre RustadInhalation apparatus
US20060124777A1 (en)*2003-06-132006-06-15Arno DrechselVacuum generating device, particularly for operating actuator members in fluid delivery systems
USD529606S1 (en)2004-04-072006-10-033M Innovative Properties CompanyAir duct
US20070062519A1 (en)*2004-02-242007-03-22Boehringer Ingelheim International GmbhNebulizer
US20080223361A1 (en)*2007-03-142008-09-18Peter NieuwstadRespiratory medicine delivery system
US20110060257A1 (en)*2009-02-062011-03-10Shoichi NakamuraGas mist pressure bath system
US8074642B2 (en)2002-05-212011-12-13Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US20120022432A1 (en)*2009-10-092012-01-26Shoichi NakamuraGas mist pressure bathing system
US20120048268A1 (en)*2010-08-132012-03-01Sinjae HyunInhalation Airflow Regulation Devices and Methods of Using the Same
US8357696B2 (en)2005-05-182013-01-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en)2005-05-182013-05-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8459252B2 (en)2002-05-022013-06-11Pari Innovative Manufacturers, Inc.Aerosol medication inhalation system
US8629139B2 (en)2008-10-072014-01-14Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
WO2014018668A2 (en)2012-07-242014-01-30Genoa Pharmaceuticals, Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
USRE45068E1 (en)2000-04-112014-08-12Trudell Medical InternationalAerosol delivery apparatus
US8815838B2 (en)2008-10-072014-08-26David C. GriffithAerosol fluoroquinolone formulations for improved pharmacokinetics
US20150352299A1 (en)*2014-06-062015-12-10Vapotherm, Inc.Heated nebulizer adapter for respiratory therapy
US9539408B2 (en)2012-10-312017-01-10Trudell Medical InternationalNebulizer apparatus
US9700564B2 (en)2009-09-042017-07-11Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
WO2019006155A1 (en)2017-06-282019-01-03Children's Medical Center CorporationPromoting lung growth
WO2019110099A1 (en)2017-12-062019-06-13Qrumpharma Inc.Inhalable clofazimine formulation
WO2020040818A1 (en)2018-08-232020-02-27Qrumpharma Inc.Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
US10682331B2 (en)*2012-02-242020-06-16Nasoneb, Inc.Nasal drug delivery and method of making same
US10786638B2 (en)2016-07-082020-09-29Trudell Medical InternationalNebulizer apparatus and method
WO2020214644A1 (en)2019-04-152020-10-22Children's Medical Center CorporationAerosolized compositions comprising mitochondria and methods of use thereof
US10850050B2 (en)2016-05-192020-12-01Trudell Medical InternationalSmart valved holding chamber
WO2020245573A1 (en)2019-06-042020-12-10Thirty Holdings LimitedMethods and compositions for generating nitric oxide and uses thereof
WO2020245574A1 (en)2019-06-042020-12-10Thirty Respiratory LimitedMethods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
EP3782604A1 (en)2013-07-312021-02-24Windward Pharma, Inc.Aerosol tyrosine kinase inhibitor compounds and uses thereof
WO2021214440A1 (en)2020-04-232021-10-28Thirty Respiratory LimitedNitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
WO2021214439A1 (en)2020-04-232021-10-28Thirty Respiratory LimitedMethods and compositions for treating and combatting tuberculosis
WO2021247542A2 (en)2020-06-012021-12-09Advent Therapeutics, Inc.Pharmaceutical compositions comprising insoluble active ingredients
US11439788B2 (en)2012-01-242022-09-13Vapotherm, Inc.Systems and methods for providing respiratory therapy
EP4059499A1 (en)2011-01-312022-09-21Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US11491480B2 (en)2014-06-132022-11-08Children's Medical Center CorporationProducts and methods to isolate mitochondria
US11497867B2 (en)2016-12-092022-11-15Trudell Medical InternationalSmart nebulizer
WO2022240897A1 (en)2021-05-102022-11-17Sepelo Therapeutics, LlcPharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en)2021-08-272023-03-02Sepelo Therapeutics, LlcTargeted compositions and uses therof
US11602601B2 (en)2018-05-312023-03-14Vapotherm, Inc.Machine proximate nebulizer
US11666801B2 (en)2018-01-042023-06-06Trudell Medical InternationalSmart oscillating positive expiratory pressure device
US11712175B2 (en)2019-08-272023-08-01Trudell Medical InternationalSmart oscillating positive expiratory pressure device with feedback indicia
US11772109B2 (en)*2018-07-132023-10-03Elysion Family Office GmbHNozzle for a nano-aerosol
US11839716B2 (en)2016-07-082023-12-12Trudell Medical InternationalSmart oscillating positive expiratory pressure device
US11878115B2 (en)2019-09-262024-01-23Vapotherm, Inc.Internal cannula mounted nebulizer
US12102755B2 (en)2018-05-312024-10-01Vapotherm, Inc.Cannula-based vibrating mesh nebulizer
US12168700B2 (en)2016-01-152024-12-17Children's Medical Center CorporationTherapeutic use of mitochondria and combined mitochondrial agents
EP4491180A1 (en)2014-01-102025-01-15Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4279250A (en)1977-11-101981-07-21Airco, Inc.Drug nebulizing system for medical ventilators of the volume-limited type
US4186737A (en)1977-11-101980-02-05Airco, Inc.Drug nebulizing system for medical ventilators of the volume-limited type
FI64896C (en)*1978-04-181984-02-10Taisto Haekkinen RESPIRATOR
FI66753C (en)*1979-01-051984-12-10Taisto Haekkinen RYTMISERINGSVENTIL FOER ANDNINGEN AVSEDD FOER RESPIRATOR ELLERFOER ANNAN UPPLIVNINGSANVAENDNING LAEMPAD ANORDNING
JPH062681Y2 (en)*1987-02-171994-01-26オムロン株式会社 Atomizer
DE3775679D1 (en)*1986-09-221992-02-13Omron Tateisi Electronics Co MISTAKER.
US8225785B2 (en)*2006-10-032012-07-24Smiths Medical Asd, Inc.Vibratory PEP therapy system with medicated aerosol nebulizer
GB201110906D0 (en)2011-06-272011-08-10Amazon Bio Guard LtdA portable apparatus for generating and broadcasting an aerosol mist
JP5991685B1 (en)*2015-12-242016-09-14株式会社 ウィズダム Sprayer and spraying apparatus using the sprayer

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2069455A (en)*1934-09-081937-02-02Robert F MassaAtomizer
US3097645A (en)*1960-03-221963-07-16Victor E LesterNebulizer
US3221733A (en)*1961-10-021965-12-07Bennett Respiration Products IPressure breathing therapy unit
US3234932A (en)*1960-09-191966-02-15Forrest M BirdRespirator
US3362404A (en)*1964-11-161968-01-09Bennett Respiration Products IRespiration apparatus for administering intermittent positive pressure breathing therapy
US3468307A (en)*1966-10-261969-09-23Carleton Controls CorpIntermittent positive pressure breathing apparatus
US3580249A (en)*1968-09-161971-05-25Kentaro TakaokaAerosol nebulizers
US3584621A (en)*1968-10-311971-06-15Bird F MRespiratory apparatus
US3664337A (en)*1970-04-151972-05-23Bio Logics IncRespiration assembly and methods

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2069455A (en)*1934-09-081937-02-02Robert F MassaAtomizer
US3097645A (en)*1960-03-221963-07-16Victor E LesterNebulizer
US3234932A (en)*1960-09-191966-02-15Forrest M BirdRespirator
US3221733A (en)*1961-10-021965-12-07Bennett Respiration Products IPressure breathing therapy unit
US3362404A (en)*1964-11-161968-01-09Bennett Respiration Products IRespiration apparatus for administering intermittent positive pressure breathing therapy
US3468307A (en)*1966-10-261969-09-23Carleton Controls CorpIntermittent positive pressure breathing apparatus
US3580249A (en)*1968-09-161971-05-25Kentaro TakaokaAerosol nebulizers
US3584621A (en)*1968-10-311971-06-15Bird F MRespiratory apparatus
US3664337A (en)*1970-04-151972-05-23Bio Logics IncRespiration assembly and methods

Cited By (163)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3903884A (en)*1973-08-151975-09-09Becton Dickinson CoManifold nebulizer system
US3940064A (en)*1974-08-191976-02-24Kentaro TakaokaAtomizing equipments for anesthetic liquid compounds
US3915386A (en)*1975-02-251975-10-28Respiratory CareNebulizer
USD245540S (en)*1975-11-261977-08-23Arbrook, Inc.Nebulizer bag
USD245539S (en)*1975-11-261977-08-23Arbrook, Inc.Nebulizer-humidifier bag assembly
US4333450A (en)*1976-12-141982-06-08Lester Victor ENebulizer-manifold
US4456179A (en)*1978-04-281984-06-26Eastfield CorporationMist generator and housing therefor
US4251033A (en)*1978-06-121981-02-17Eastfield CorporationMist generating structure and molding apparatus therefor
US4210155A (en)*1978-08-031980-07-01Jerry GrimesInspirational inhalation spirometer apparatus
US4253468A (en)*1978-08-141981-03-03Steven LehmbeckNebulizer attachment
US4198969A (en)*1978-10-061980-04-22Baxter Travenol Laboratories, Inc.Suction-operated nebulizer
USRE32553E (en)*1978-11-291987-12-08Exhalation valve assembly
DE2947363A1 (en)*1978-11-291980-06-19Bard Inc C R EXHALATION VALVE
US4343304A (en)*1980-07-171982-08-10Hickmann Horst RVeterinary inhalation therapy apparatus
US4462397A (en)*1981-04-031984-07-31Terumo CorporationBreathing circuit
US4471773A (en)*1981-11-191984-09-18Bunnell Life System, Inc.Apparatus and method for delivering medication to patient's respiratory system
US4566451A (en)*1982-07-021986-01-28Plantorgan Werk Heinrich G. E. Christensen KgVapor inhalation device
US4512341A (en)*1982-11-221985-04-23Lester Victor ENebulizer with capillary feed
USRE33642E (en)*1982-11-221991-07-23Hudson Oxygen Therapy Sales CompanyNebulizer with capillary feed
US4560519A (en)*1983-06-031985-12-24Respiratory Care, Inc.Self-contained nebulizer and system
DE3341711A1 (en)*1983-11-181985-05-30Drägerwerk AG, 2400 Lübeck CONTROLLABLE DIAPHRAGM VALVE FOR VENTILATORS
US4694825A (en)*1983-11-181987-09-22Dragerwerk AgControl for respirators
US5020532A (en)*1988-11-141991-06-04Baxter International Inc.Exhalation valve for respiratory circuit
US5027809A (en)*1990-05-171991-07-02Robinson Pat D"Peeper" performance hand held nebuilizer attachment with adjustability of expiratory pressures and expiratory restriction
US5235969A (en)*1990-08-201993-08-17Intersurgical (Guernsey) LimitedNebulizer having combined structure for removing particles over two microns
US5062419A (en)*1991-01-071991-11-05Rider Donald LNebulizer with valved "T" assembly
US5301663A (en)*1991-07-161994-04-12Healthscan Products, Inc.Aerosol delivery system
US6468798B1 (en)1991-12-172002-10-22The Regents Of The University Of CaliforniaExpression of cloned genes in the lung by aerosol and liposome-based delivery
US5641662A (en)*1991-12-171997-06-24The Regents Of The University Of CaliforniaTransfection of lung via aerosolized transgene delivery
US5756353A (en)*1991-12-171998-05-26The Regents Of The University Of CaliforniaExpression of cloned genes in the lung by aerosol-and liposome-based delivery
US5858784A (en)*1991-12-171999-01-12The Regents Of The University Of CaliforniaExpression of cloned genes in the lung by aerosol- and liposome-based delivery
US6001644A (en)*1991-12-171999-12-14The Regents Of The University Of CaliforniaMammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US6627615B1 (en)1991-12-172003-09-30The Regents Of The University Of CaliforniaMethods and compositions for in vivo gene therapy
US6620795B1 (en)1991-12-172003-09-16The Regents Of The University Of CaliforniaMammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US6806084B1 (en)1992-06-042004-10-19The Regents Of The University Of CaliforniaMethods for compositions for in vivo gene delivery
US5827703A (en)*1992-06-041998-10-27The Regents Of The University Of CaliforniaMethods and composition for in vivo gene therapy
US6076519A (en)*1993-12-142000-06-20Ethex International, Inc.Passive inspiratory nebulizer system
US5570682A (en)*1993-12-141996-11-05Ethex International, Inc.Passive inspiratory nebulizer system
US5611332A (en)*1995-03-221997-03-18Bono; MichaelAerosol inhalation device containing a rain-off chamber
US6748945B2 (en)1996-02-132004-06-15Trudell Medical InternationalNebulizer apparatus and method
US6644304B2 (en)1996-02-132003-11-111263152 Ontario Inc.Nebulizer apparatus and method
US20040173209A1 (en)*1996-02-132004-09-09Trudell Medical International.Nebulizer apparatus and method
US20070204864A1 (en)*1996-02-132007-09-06Trudell Medical InternationalAerosol Delivery Apparatus And Method
US7080643B2 (en)1996-02-132006-07-25Trudell Medical InternationlNebulizer apparatus and method
US7634995B2 (en)1996-02-132009-12-22Trudell Medical InternationalNebulizer apparatus and method
US6612303B1 (en)1996-02-132003-09-021263152 Ontario Inc.Nebulizer apparatus and method
US8061352B2 (en)1996-02-132011-11-22Trudell Medical InternationalAerosol delivery apparatus and method
US6044841A (en)*1997-08-292000-04-041263152 Ontario Inc.Breath actuated nebulizer with valve assembly having a relief piston
US6450163B1 (en)1997-08-292002-09-17Trudell Medical InternationalBreath actuated nebulizer with valve assembly having a relief piston
US6631721B1 (en)*1998-11-062003-10-14Salter LabsNebulizer mouthpiece and accessories
US20040040557A1 (en)*1998-11-062004-03-04Salter Peter W.Nebulizer mouthpiece and accessories
US6904906B2 (en)1998-11-062005-06-14Salter LabsNebulizer mouthpiece and accessories
US6328030B1 (en)*1999-03-122001-12-11Daniel E. KidwellNebulizer for ventilation system
US6314609B1 (en)*2000-02-072001-11-13Connie GeorgeMouth powered vacuum
USRE46050E1 (en)2000-04-112016-07-05Trudell Medical InternationalAerosol delivery apparatus
USRE45068E1 (en)2000-04-112014-08-12Trudell Medical InternationalAerosol delivery apparatus
US6718979B1 (en)2000-06-052004-04-13Dhd Healthcare CorporationOxygen mask assembly
US20020121275A1 (en)*2000-07-062002-09-05Clinical Technologies, Inc.Aerosol enhancement device
US7204245B2 (en)2000-07-062007-04-17Clinical Technologies, IncAerosol enhancement device
US6363932B1 (en)2000-07-062002-04-02Clinical Technologies, Inc.Aerosol enhancement device
US20070169774A1 (en)*2000-07-062007-07-26Clinical Technologies, Inc.Aerosol enhancement device
US6929003B2 (en)2001-03-202005-08-16Trudell Medical InternationalNebulizer apparatus and method
US9364618B2 (en)2001-03-202016-06-14Trudell Medical InternationalNebulizer apparatus and method
US20050205085A1 (en)*2001-03-202005-09-22Trudell Medical InternationalNebulizer apparatus and method
US7905228B2 (en)2001-03-202011-03-15Trudell Medical InternationalNebulizer apparatus and method
US9907918B2 (en)2001-03-202018-03-06Trudell Medical InternationalNebulizer apparatus and method
US20020157663A1 (en)*2001-03-202002-10-31Rick BlackerNebulizer apparatus and method
US7131439B2 (en)2001-03-202006-11-07Trudell Medical InternationalNebulizer apparatus and method
US20030037785A1 (en)*2001-06-012003-02-27Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy apparatus having a valve for limiting the inspiration flow
US20090272820A1 (en)*2001-12-212009-11-05Trudell Medical InternationalNebulizer apparatus and method
US6994083B2 (en)2001-12-212006-02-07Trudell Medical InternationalNebulizer apparatus and method
US20030136399A1 (en)*2001-12-212003-07-24Foley Martin P.Nebulizer apparatus and method
US8397712B2 (en)2001-12-212013-03-19Trudell Medical InternationalNebulizer apparatus and method
US8844520B2 (en)2001-12-212014-09-30Trudell Medical InternationalNebulizer apparatus and method
US20060157052A1 (en)*2001-12-212006-07-20Trudell Medical InternationalNebulizer apparatus and method
US20060213507A1 (en)*2001-12-212006-09-28Trudell Medical InternationalNebulizer apparatus and method
US7559322B2 (en)2001-12-212009-07-14Trudell Medical InternationalNebulizer apparatus and method
US7568480B2 (en)2001-12-212009-08-04Trudell Medical InternationalNebulizer apparatus and method
US8459252B2 (en)2002-05-022013-06-11Pari Innovative Manufacturers, Inc.Aerosol medication inhalation system
US8973571B1 (en)2002-05-022015-03-10Pre Holding, Inc.Aerosol medication inhalation system
US9308335B2 (en)2002-05-022016-04-12Pre Holding, Inc.Aerosol medication inhalation system
US8074642B2 (en)2002-05-212011-12-13Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US9814849B2 (en)2002-05-212017-11-14Trudell Medical InternationalMedication delivery apparatus and system and methods for the use and assembly thereof
US9700689B2 (en)2002-05-212017-07-11Trudell Medical InternationalMedication delivery apparatus and system and methods for the use and assembly thereof
US10881816B2 (en)2002-05-212021-01-05Trudell Medical InternationalMedication delivery apparatus and system and methods for the use and assembly thereof
US8550067B2 (en)2002-05-212013-10-08Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US20040031485A1 (en)*2002-08-192004-02-19Andre RustadSmall volume nebulizer
US7267120B2 (en)2002-08-192007-09-11Allegiance CorporationSmall volume nebulizer
US20060124777A1 (en)*2003-06-132006-06-15Arno DrechselVacuum generating device, particularly for operating actuator members in fluid delivery systems
US7954487B2 (en)2003-08-132011-06-07Trudell Medical InternationalNebulizer apparatus and method
US7270123B2 (en)2003-08-132007-09-18Trudell Medical InternationalNebulizer apparatus and method
US20080083407A1 (en)*2003-08-132008-04-10Trudell Medical InternationalNebulizer Apparatus And Method
US20050081844A1 (en)*2003-08-132005-04-21Jerry GrychowskiNubulizer apparatus and method
US7571722B2 (en)2004-02-242009-08-11Boehringer Ingelheim International GmbhNebulizer
US20070062519A1 (en)*2004-02-242007-03-22Boehringer Ingelheim International GmbhNebulizer
USD529606S1 (en)2004-04-072006-10-033M Innovative Properties CompanyAir duct
US20050252509A1 (en)*2004-05-142005-11-17Andre RustadInhalation apparatus
US7721734B2 (en)*2004-05-142010-05-25Carefusion 2200, Inc.Inhalation apparatus
US8524735B2 (en)2005-05-182013-09-03Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en)2005-05-182013-10-01Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8524734B2 (en)2005-05-182013-09-03Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en)2005-05-182013-05-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8357696B2 (en)2005-05-182013-01-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US10987357B2 (en)2005-05-182021-04-27Horizon Orphan, LLCAerosolized fluoroquinolones and uses thereof
US20080223361A1 (en)*2007-03-142008-09-18Peter NieuwstadRespiratory medicine delivery system
US10149854B2 (en)2008-10-072018-12-11Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US9717738B2 (en)2008-10-072017-08-01Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US9326936B2 (en)2008-10-072016-05-03Raptor Pharmaceuticals, Inc.Aerosol fluoroquinolone formulations for improved pharmacokinetics
US11020481B2 (en)2008-10-072021-06-01Horizon Orphan LlcTopical use of levofloxacin for reducing lung inflammation
US10722519B2 (en)2008-10-072020-07-28Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en)2008-10-072014-01-14Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
US8815838B2 (en)2008-10-072014-08-26David C. GriffithAerosol fluoroquinolone formulations for improved pharmacokinetics
US20110060257A1 (en)*2009-02-062011-03-10Shoichi NakamuraGas mist pressure bath system
US10231975B2 (en)2009-09-042019-03-19Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
EP3569235A1 (en)2009-09-042019-11-20Horizon Orphan LLCUse of aerosolized levofloxacin for treating cystic fibrosis
US9700564B2 (en)2009-09-042017-07-11Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US10792289B2 (en)2009-09-042020-10-06Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US8961478B2 (en)*2009-10-092015-02-24Acp Japan Co., Ltd.Gas mist pressure bathing system
US20120022432A1 (en)*2009-10-092012-01-26Shoichi NakamuraGas mist pressure bathing system
US8944050B2 (en)*2010-08-132015-02-03The Corporation Of Mercer UniversityInhalation airflow regulation devices and methods of using the same
US20120048268A1 (en)*2010-08-132012-03-01Sinjae HyunInhalation Airflow Regulation Devices and Methods of Using the Same
EP4059499A1 (en)2011-01-312022-09-21Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US11439788B2 (en)2012-01-242022-09-13Vapotherm, Inc.Systems and methods for providing respiratory therapy
US11975164B2 (en)*2012-02-242024-05-07Monaghan Medical CorporationNasal drug delivery device and method of making same
US10682331B2 (en)*2012-02-242020-06-16Nasoneb, Inc.Nasal drug delivery and method of making same
US20210030711A1 (en)*2012-02-242021-02-04Nasoneb, Inc.Nasal drug delivery device and method of making same
WO2014018668A2 (en)2012-07-242014-01-30Genoa Pharmaceuticals, Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10668229B2 (en)2012-10-312020-06-02Trude Medical InternationalNebulizer apparatus
US9539408B2 (en)2012-10-312017-01-10Trudell Medical InternationalNebulizer apparatus
EP3782604A1 (en)2013-07-312021-02-24Windward Pharma, Inc.Aerosol tyrosine kinase inhibitor compounds and uses thereof
EP4491180A1 (en)2014-01-102025-01-15Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10512748B2 (en)*2014-06-062019-12-24Vapotherm, Inc.Heated nebulizer adapter for respiratory therapy
US20150352299A1 (en)*2014-06-062015-12-10Vapotherm, Inc.Heated nebulizer adapter for respiratory therapy
US11491480B2 (en)2014-06-132022-11-08Children's Medical Center CorporationProducts and methods to isolate mitochondria
US12168700B2 (en)2016-01-152024-12-17Children's Medical Center CorporationTherapeutic use of mitochondria and combined mitochondrial agents
US10850050B2 (en)2016-05-192020-12-01Trudell Medical InternationalSmart valved holding chamber
US11975140B2 (en)2016-05-192024-05-07Trudell Medical InternationalMedication delivery system with mask
US12097320B2 (en)2016-07-082024-09-24Trudell Medical International Inc.Nebulizer apparatus and method
US10786638B2 (en)2016-07-082020-09-29Trudell Medical InternationalNebulizer apparatus and method
US11839716B2 (en)2016-07-082023-12-12Trudell Medical InternationalSmart oscillating positive expiratory pressure device
US11497867B2 (en)2016-12-092022-11-15Trudell Medical InternationalSmart nebulizer
EP4410368A2 (en)2017-06-282024-08-07Children's Medical Center CorporationPromoting lung growth
WO2019006155A1 (en)2017-06-282019-01-03Children's Medical Center CorporationPromoting lung growth
WO2019110099A1 (en)2017-12-062019-06-13Qrumpharma Inc.Inhalable clofazimine formulation
US11666801B2 (en)2018-01-042023-06-06Trudell Medical InternationalSmart oscillating positive expiratory pressure device
US12214252B2 (en)2018-01-042025-02-04Trudell Medical International Inc.Smart oscillating positive expiratory pressure device
US11964185B2 (en)2018-01-042024-04-23Trudell Medical InternationalSmart oscillating positive expiratory pressure device
US11602601B2 (en)2018-05-312023-03-14Vapotherm, Inc.Machine proximate nebulizer
US12102755B2 (en)2018-05-312024-10-01Vapotherm, Inc.Cannula-based vibrating mesh nebulizer
US12350422B2 (en)2018-05-312025-07-08Vapotherm, Inc.Machine proximate nebulizer
US11772109B2 (en)*2018-07-132023-10-03Elysion Family Office GmbHNozzle for a nano-aerosol
WO2020040818A1 (en)2018-08-232020-02-27Qrumpharma Inc.Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
EP4461369A2 (en)2019-04-152024-11-13Children's Medical Center CorporationAerosolized compositions comprising mitochondria and methods of use thereof
WO2020214644A1 (en)2019-04-152020-10-22Children's Medical Center CorporationAerosolized compositions comprising mitochondria and methods of use thereof
WO2020245573A1 (en)2019-06-042020-12-10Thirty Holdings LimitedMethods and compositions for generating nitric oxide and uses thereof
WO2020245574A1 (en)2019-06-042020-12-10Thirty Respiratory LimitedMethods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
US11712175B2 (en)2019-08-272023-08-01Trudell Medical InternationalSmart oscillating positive expiratory pressure device with feedback indicia
US11878115B2 (en)2019-09-262024-01-23Vapotherm, Inc.Internal cannula mounted nebulizer
WO2021214439A1 (en)2020-04-232021-10-28Thirty Respiratory LimitedMethods and compositions for treating and combatting tuberculosis
WO2021214440A1 (en)2020-04-232021-10-28Thirty Respiratory LimitedNitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
WO2021247542A2 (en)2020-06-012021-12-09Advent Therapeutics, Inc.Pharmaceutical compositions comprising insoluble active ingredients
WO2022240897A1 (en)2021-05-102022-11-17Sepelo Therapeutics, LlcPharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en)2021-08-272023-03-02Sepelo Therapeutics, LlcTargeted compositions and uses therof

Also Published As

Publication numberPublication date
DE2331525C3 (en)1979-02-01
JPS4951796A (en)1974-05-20
DE2331525A1 (en)1974-01-31
SE402865B (en)1978-07-24
AU5704873A (en)1974-12-19
JPS5239277B2 (en)1977-10-04
NL7308327A (en)1973-12-27
ZA733952B (en)1974-05-29
CA1003292A (en)1977-01-11
JPS50143391A (en)1975-11-18
JPS5131480B2 (en)1976-09-07
DE2331525B2 (en)1978-05-24
NO135345B (en)1976-12-20
AU468299B2 (en)1976-01-08
NO135345C (en)1977-03-30
GB1431082A (en)1976-04-07
GB1431081A (en)1976-04-07
BE801216A (en)1973-10-15

Similar Documents

PublicationPublication DateTitle
US3826255A (en)Intermittent positive pressure breathing manifold
EP0957960B1 (en)Breathing circuit apparatus for a nebulizer
US3580249A (en)Aerosol nebulizers
US3572660A (en)Device for dispensing inhalable fluids
US5062419A (en)Nebulizer with valved "T" assembly
US4198969A (en)Suction-operated nebulizer
US3874379A (en)Manifold nebulizer system
US4061698A (en)Humidifier-nebulizer apparatus
US3664337A (en)Respiration assembly and methods
US3903884A (en)Manifold nebulizer system
US5727542A (en)General purpose aerosol inhalation apparatus
US4333450A (en)Nebulizer-manifold
US6340023B2 (en)Rebreather nebulizer device
US5036847A (en)Breathing aid
US3762409A (en)Nebulizer
JP3246945B2 (en) Aerosol inhaler
US4267974A (en)Nebulizer device
US4592349A (en)Ventilator having an oscillatory inspiratory phase and method
EP1455871B1 (en)Nebulizer apparatus and method
US4774941A (en)Resuscitator bag
US4231973A (en)Nebulizer with variable flow rate control and associated method
US7047968B2 (en)Device for generating a continuous positive airway pressure (CPAP device)
US3744771A (en)Disposable liquid entraining system
US20080110463A1 (en)Nebulizer mask for delivery of aerosolized and nebulized medications
US4054622A (en)Combination nebulizer and humidifier

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:FIRST INTERSTATE BANK OF CALIFORNIA

Free format text:SECURITY INTEREST;ASSIGNOR:HUDSON RESPIRATORY CARE, INC.;REEL/FRAME:005302/0948

Effective date:19900209

ASAssignment

Owner name:HOMEFED BANK, F.S.B.

Free format text:SECURITY INTEREST;ASSIGNOR:HUDSON RESPIRATORY CARE INC.;REEL/FRAME:005300/0204

Effective date:19900509

ASAssignment

Owner name:CREDITANSTALT-BANKVEREIN, CALIFORNIA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HUDSON RESPIRATORY CARE INC.;REEL/FRAME:006570/0759

Effective date:19920914


[8]ページ先頭

©2009-2025 Movatter.jp